Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatment (Q26991865)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25117007%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Gabriel A Rabinovich

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25117007%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Diego O Croci

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25117007%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Juan P Cerliani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25117007%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Nicolas A Pinto

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25117007%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

language of work or name

1 reference

December 2014

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25117007%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25117007%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25117007%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

1283-1290

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25117007%20AND%20SRC:MED&resulttype=core&format=json

Dendritic cell maturation results in pronounced changes in glycan expression affecting recognition by siglecs and galectins

2 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Modes of resistance to anti-angiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Glycosylation, galectins and cellular signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Modulation of endothelial cell migration and angiogenesis: a novel function for the "tandem-repeat" lectin galectin-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Molecular mechanisms and clinical applications of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Circulating galectins -2, -4 and -8 in cancer patients make important contributions to the increased circulation of several cytokines and chemokines that promote angiogenesis and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

VEGFR1 and VEGFR2 involvement in extracellular galectin-1- and galectin-3-induced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Scheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Interfering with Gal-1-mediated angiogenesis contributes to the pathogenesis of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Activation of human endothelial cells by tumor necrosis factor-α results in profound changes in the expression of glycosylation-related genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Bevacizumab plus ipilimumab in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Alpha2,6-sialic acid on platelet endothelial cell adhesion molecule (PECAM) regulates its homophilic interactions and downstream antiapoptotic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Galectin-1: a link between tumor hypoxia and tumor immune privilege

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Galectin-3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1-induced macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

A systematic approach to protein glycosylation analysis: a path through the maze

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Galectin-3 protein modulates cell surface expression and activation of vascular endothelial growth factor receptor 2 in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Galectin-1 drives pancreatic carcinogenesis through stroma remodeling and Hedgehog signaling activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Galectin-1 in melanoma biology and related neo-angiogenesis processes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

The role of myeloid cells in the promotion of tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Galectin-3 induces endothelial cell morphogenesis and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Cleavage of galectin-3 by matrix metalloproteases induces angiogenesis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Glycosylation in cellular mechanisms of health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Basic and therapeutic aspects of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

HGF/c-Met Acts as an Alternative Angiogenic Pathway in Sunitinib-Resistant Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Bv8 regulates myeloid-cell-dependent tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Regulation of Notch signaling during T- and B-cell development by O-fucose glycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Genes expressed in human tumor endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Tumor cells secrete galectin-1 to enhance endothelial cell activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Protein-glycan interactions in the control of innate and adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Interfering with UDP-GlcNAc metabolism and heparan sulfate expression using a sugar analogue reduces angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Transcriptional regulation of the vascular endothelial glycome by angiogenic and inflammatory signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Heparan sulfate regulates VEGF165- and VEGF121-mediated vascular hyperpermeability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Synergistic induction of galectin-1 by CCAAT/enhancer binding protein alpha and hypoxia-inducible factor 1alpha and its role in differentiation of acute myeloid leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

Pharmacokinetics and antineoplastic activity of galectin-1-targeting OTX008 in combination with sunitinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWU083

21 January 2018

Identifiers

DOI

10.1093/GLYCOB/CWU083

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25117007%20AND%20SRC:MED&resulttype=core&format=json

release_fzjfwibgdjesvgdlxkxxzp7edu

2 June 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fzjfwibgdjesvgdlxkxxzp7edu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25117007%20AND%20SRC:MED&resulttype=core&format=json